SCHEMBL571808

SCHEMBL571808

Nc1cc(O)cc(C(=O)O)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.68
CA1 P00915 5/20 0.68
CA2 P00918 5/20 0.68
CA9 Q16790 5/20 0.68
CA7 P43166 4/20 0.68
CA14 Q9ULX7 4/20 0.68
HCAR1 Q9BXC0 3/20 0.56
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
LMNA P02545 2/20 0.48
DDO Q99489 1/20 0.48
CA6 P23280 4/20 0.46
CA5A P35218 4/20 0.46
CA3 P07451 3/20 0.46
CA4 P22748 3/20 0.46
CA5B Q9Y2D0 3/20 0.46
TPMT P51580 3/20 0.46
MAPT P10636 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29581511 1.00 CA12 (0.68) CA12CA1CA2CA9CA7
Hydrochloric Acid SCHEMBL2178065 0.98 CA12 (0.65) CA12CA1CA2CA9CA7
SCHEMBL223304 0.85 KDM4E (0.56) CA12CA1CA2CA9CA7
SCHEMBL109155 0.85 KDM4E (0.56) CA12CA1CA2CA9CA7
SCHEMBL2820215 0.85 KDM4E (0.56) CA12CA1CA2CA9CA7
SCHEMBL6131087 0.84 CA12 (0.54) CA12CA1CA2CA9CA7
Hydrochloric Acid SCHEMBL8653192 0.82 KDM4E (0.54) CA12CA1CA2CA9CA7
SCHEMBL613113 0.82 KDM4E (0.54) CA12CA1CA2CA9CA7
Water SCHEMBL2806532 0.82 KDM4E (0.54) CA12CA1CA2CA9CA7
Hydrochloric Acid SCHEMBL9311860 0.82 KDM4E (0.54) CA12CA1CA2CA9CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 526 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP claimed
EP-4673458-A1 METHODS OF ENHANCING PRODUCTION OF METABOLITES IN BACTERIA JOHN INNES CENTRE (GB) 2026-01-07 EP claimed
WO-2025019764-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS MATTERWORKS INC (US) 2025-01-23 WO claimed
EP-4437319-A1 METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION Matterworks Inc (US) 2024-10-02 EP claimed
US-12086639-B2 Server management system capable of supporting multiple vendors GeniAI CO.,LTD (KR) 2024-09-10 US claimed
WO-2024180095-A1 METHODS OF ENHANCING PRODUCTION OF METABOLITES IN BACTERIA JOHN INNES CENTRE (GB) 2024-09-06 WO claimed
CN-118221889-B Temperature-resistant polymer gel water shutoff agent and preparation process 胜利油田金岛石油工程技术有限责任公司 2024-09-03 CN claimed
CN-118221889-A Temperature-resistant polymer gel water shutoff agent and preparation process 胜利油田金岛石油工程技术有限责任公司 2024-06-21 CN claimed
CN-118184679-A Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material 中国石油天然气股份有限公司 2024-06-14 CN claimed
CN-116103711-A Forward and reverse pulse electrolytic nickel-phosphorus alloy solution, preparation method, electroplating method and nickel-phosphorus alloy coating 安徽智备工业科技有限公司 2023-05-12 CN claimed
EP-1381672-A4 BIOSYNTHESIS OF POLYKETIDE SYNTHASE SUBSTRATES TRUSTEES OF BOARD OF (US) 2006-01-25 EP claimed
US-20040116430-A1 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2004-06-17 US claimed
EP-1381672-A1 BIOSYNTHESIS OF POLYKETIDE SYNTHASE SUBSTRATES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2004-01-21 EP claimed
US-6653316-B1 Coronary artery and cerebrovascular diseases PHARMACIA CORPORATION 2003-11-25 US claimed
US-20020192767-A1 Biosynthesis of polyketide synthase substrates NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-12-19 US claimed
WO-2002068613-A1 BIOSYNTHESIS OF POLYKETIDE SYNTHASE SUBSTRATES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2002-09-06 WO claimed
US-20020045220-A1 Biosynthesis of polyketide synthase substrates LELAND STANFORD JUNIOR UNIVERSITY, THE 2002-04-18 US claimed
WO-2001087851-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIMIDINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO claimed
WO-2001087842-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRIDONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO claimed
WO-1999044996-A1 PROCESS FOR PREPARING 3- HYDROXY- 5-[(1, 4,5,6- TETRAHYDRO-5-HYDROXY- 2- PYRIMIDINYL)AMINO]BENZOIC ACID G. S. SEARLE & CO. (US) 1999-09-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045220-A1 Biosynthesis of polyketide synthase substrates COASY, DCXR, KYAT3 CA12 2881/4885CA1 3523/4885CA2 4173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.